Tuesday’s Highlights at Noon: Growlife Inc (PHOT), NQ Mobile (NQ), Second Sight Medical Products (EYES), Biocept Inc (BIOC), EKSO BIONICS (EKSO)

By Carrie Williams

So far Tuesday, February 6, NASDAQ is up 5.14% and the S&P is up 4.08%. Here are this morning’s most active stocks: Growlife Inc (Other OTC:PHOT), NQ Mobile (NYSE:NQ), Second Sight Medical Products (NASDAQ:EYES), Biocept Inc (NASDAQ:BIOC) and EKSO BIONICS (NASDAQ:EKSO).

Growlife Inc is up 21.38% in midday trading to $0.02. Shares opened today at $0.01. The company has a 52-week low of $0.00 and a 52-week high of $0.05.

NQ Mobile is down -15.03% in midday trading to $2.43. Shares opened today at $2.86. The company has a 52-week low of $2.43 and a 52-week high of $4.68. On the Street’s front, the average 12-month analyst price target for the stock is $13, marking a 354.55% potential upside from current levels. In a report issued on December 21, Rosenblatt Securities analyst Jun Zhang assigned a Buy rating on NQ, with a price target of $13, which implies an upside of 355% from current levels.

Second Sight Medical Products is down -12.39% in midday trading to $1.98. Shares opened today at $2.26. The company has a 52-week low of $0.90 and a 52-week high of $2.83. On the Street’s front, the average 12-month analyst price target for the stock is $5, marking a 121.24% potential upside from current levels. In a report released yesterday, H.C. Wainwright analyst Amit Dayal assigned a Buy rating on EYES, with a price target of $5, which represents a potential upside of 121% from where the stock is currently trading. Over the last 3 months, the insider sentiment on Second Sight Medical Products has been positive based on 23 corporate insider transactions. This sentiment is slightly higher than the average sector sentiment of insiders.

Biocept Inc is down -10.99% in midday trading to $0.32. Shares opened today at $0.37. The company has a 52-week low of $0.30 and a 52-week high of $2.76.

EKSO BIONICS is up 10.8% in midday trading to $1.39. Shares opened today at $1.25. The company has a 52-week low of $0.99 and a 52-week high of $4.77. Over the last 3 months, the insider sentiment on EKSO BIONICS has been negative based on 15 corporate insider transactions. This sentiment is lower than the average sector sentiment of insiders.